₨
690.00
Jun 7
Business Description
Abbott Laboratories (Pakistan) Ltd
ISIN : PK0025701019
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 20.97 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | 164.45 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.74 | |||||
Beneish M-Score | -2 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.3 | |||||
3-Year EBITDA Growth Rate | -17.4 | |||||
3-Year Book Growth Rate | 5.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 75.36 | |||||
9-Day RSI | 72.4 | |||||
14-Day RSI | 73.36 | |||||
6-1 Month Momentum % | 22.96 | |||||
12-1 Month Momentum % | 54.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.55 | |||||
Quick Ratio | 0.65 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 109.95 | |||||
Days Sales Outstanding | 10.97 | |||||
Days Payable | 85.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.11 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.69 | |||||
Operating Margin % | 5.64 | |||||
Net Margin % | 3.47 | |||||
FCF Margin % | -3.54 | |||||
ROE % | 11.37 | |||||
ROA % | 5.42 | |||||
ROIC % | 7.7 | |||||
ROC (Joel Greenblatt) % | 31.31 | |||||
ROCE % | 21.52 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 33.79 | |||||
PE Ratio without NRI | 34.04 | |||||
Shiller PE Ratio | 16.92 | |||||
PEG Ratio | 7.24 | |||||
PS Ratio | 1.16 | |||||
PB Ratio | 3.41 | |||||
Price-to-Tangible-Book | 3.41 | |||||
Price-to-Operating-Cash-Flow | 82.55 | |||||
EV-to-EBIT | 15.24 | |||||
EV-to-EBITDA | 11 | |||||
EV-to-Revenue | 1.11 | |||||
EV-to-FCF | -31.47 | |||||
Price-to-Projected-FCF | 2.04 | |||||
Price-to-DCF (Earnings Based) | 2.95 | |||||
Price-to-Median-PS-Value | 0.55 | |||||
Price-to-Graham-Number | 2.27 | |||||
Price-to-Net-Current-Asset-Value | 10.71 | |||||
Earnings Yield (Greenblatt) % | 6.56 | |||||
FCF Yield % | -3.02 | |||||
Forward Rate of Return (Yacktman) % | 5.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Abbott Laboratories (Pakistan) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₨) | 57,698.28 | ||
EPS (TTM) (₨) | 20.42 | ||
Beta | 0 | ||
Volatility % | 42.53 | ||
14-Day RSI | 73.36 | ||
14-Day ATR (₨) | 20.821952 | ||
20-Day SMA (₨) | 675.651 | ||
12-1 Month Momentum % | 54.83 | ||
52-Week Range (₨) | 330 - 698 | ||
Shares Outstanding (Mil) | 97.9 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Abbott Laboratories (Pakistan) Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Abbott Laboratories (Pakistan) Ltd Stock Events
Event | Date | Price(₨) | ||
---|---|---|---|---|
No Event Data |
Abbott Laboratories (Pakistan) Ltd Frequently Asked Questions
What is Abbott Laboratories (Pakistan) Ltd(KAR:ABOT)'s stock price today?
When is next earnings date of Abbott Laboratories (Pakistan) Ltd(KAR:ABOT)?
Does Abbott Laboratories (Pakistan) Ltd(KAR:ABOT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |